stopping glp 1 after weight loss What Happens When You Stop GLP-1s — And How to Prevent Regain What Happens When Patients Stop
Description
GLP-1 drugs aren't just changing waistlines they're changing what Canadians put in their grocery carts
Schedule a consultation now!
Recent estimates suggest that around 1.6 million adults used GLP-1 weight-loss drugs between early 2024 and early 2025, while broader data indicates up to 1.5 million people are currently taking them at any one time1
Because research peptides are frequently "over- or underfilled" (containing slightly more or less milligrams than the target
Discover the safety, monitoring requirements, and prescribing considerations for tirzepatide in patients with a single functioning kidney, based on UK clinical guidance.
Pfizer is developing a long-acting GLP-1 drug that could compete directly with Eli Lilly's Mounjaro and Zepbound when it reaches the Canadian market.
